iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Mankind Pharma Ltd Option Chain

Add as a Preferred Source on Google
₹2,492.8
(0.95%)
Oct 30, 2026|03:59:26 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,920₹1.3 0%1,0000%
--1,960₹1.3 0%1,5000%
--2,000₹1.5 -9.09%23,250-3.12%
--2,040₹1.85 2.77%3,25030%
--2,060₹3.4 0%4,5000%
--2,080₹19.1 0%1,5000%
--2,100₹2.1 -12.5%26,5004.95%
--2,120₹5.25 -0.94%1,0000%
--2,140₹3 0%2,750-8.33%
--2,160₹3.9 5.4%5,5000%
5000%₹123.1 0%2,180₹5.2 0%7,2500%
3,2500%₹312 0%2,200₹4.5 -19.64%1,06,0003.16%
--2,220₹4.7 -25.98%14,75078.78%
3,0000%₹244.9 0%2,240₹5.75 -23.84%11,500-16.36%
10,500-2.32%₹252.05 -10.87%2,260₹7 -23.07%26,000-2.80%
13,2500%₹223.7 4.04%2,280₹9.35 -15.38%26,500-23.18%
56,000-1.32%₹216.15 11.79%2,300₹10.25 -23.22%1,79,000-5.41%
2,7500%₹194.75 0%2,320₹12.6 -23.17%22,75035.82%
22,5000%₹182.6 0%2,340₹12.6 -36.52%33,2500.75%
5000%₹101 0%2,360₹18.5 -22.91%9,5002.70%
00%₹174 0%2,380₹21 -28.2%10,000-6.97%
71,750-2.71%₹129 9.5%2,400₹27.7 -21.52%80,7500.62%
4,7500%₹101.55 -0.19%2,420₹33.2 -21.14%27,25026.74%
5,5000%₹91.9 0.76%2,440₹39.8 -20.08%1,25,7500.39%
17,5006.06%₹91.85 14.81%2,460₹47.7 -18.46%20,75010.66%
36,25033.02%₹78.15 12.44%2,480₹55.25 -18.92%93,2509.06%
1,30,750-7.92%₹70.1 16.63%2,500₹65.35 -15.45%1,03,0005.37%
43,00011.68%₹59.4 13.9%2,520₹75.1 -16.83%23,50036.23%
80,00068.42%₹51 14.09%2,540₹86.8 -15.97%14,50065.71%
52,5006.06%₹43.3 13.05%2,560₹98.9 -8.29%4,500-10%
20,25088.37%₹36.6 11.75%2,580₹120 -0.33%1,5000%
1,56,7507.54%₹31.65 14.46%2,600₹121.55 -4.17%2,25012.5%
16,75028.84%₹27.25 15.46%2,620--
26,25025%₹23.65 17.95%2,640--
11,000-42.10%₹17.9 5.29%2,660--
11,250-6.25%₹17 18.05%2,680--
93,500-2.85%₹13.25 6.85%2,700₹202 0%2500%
11,2502.27%₹10.7 0%2,720--
11,250-4.25%₹9 -0.55%2,740--
10,50013.51%₹7.2 -7.69%2,760--
68,7504.56%₹5.95 1.7%2,800--
11,2507.14%₹6.75 56.97%2,840--
33,50039.58%₹3.1 10.71%2,880--

Mankind Pharma: Related NEWS

Mankind Pharma Q1 Updates: Net profit down ~18%

The company also informed that its diluted earnings per share (EPS) slipped by 20.10% on a yearly basis to ₹10.60.

1 Aug 2025|01:41 PM
Read More
Top Stocks for Today - 01st August 2025

Here are some of the stocks that may see significant price movement today: Coal India, Mankind Pharma, Swiggy, etc.

1 Aug 2025|08:58 AM
Read More
Mankind Pharma posts mixed performance in Q4; stock slips ~4%

The business said that it logged a 10.70% year-on-year decline in its consolidated net profit at ₹420.80 Crore for Q4FY25.

22 May 2025|12:15 PM
Read More
Top Stocks for Today - 22nd May 2025

Here are some of the stocks that may see significant price movement today: NBCC, IndusInd Bank, Hindustan Zinc, etc.

22 May 2025|06:38 AM
Read More
Mankind Pharma Faces ₹183.11 Crore Tax Demand

The cumulative demand, including interest charges, is ₹183.11 crore.

30 Mar 2025|04:34 PM
Read More
Mankind Pharma Merges Three Subsidiaries

The merger took effect on March 29, 2025, after all necessary regulatory approvals were obtained.

30 Mar 2025|01:33 PM
Read More
Mankind Pharma Faces ₹111.68 Crore Tax Demand, Plans to Appeal

The tax adjustments pertain to Section 80IC/80IE, which involves deductions for businesses in special economic zones, and a disallowance of certain expenditures under Section 37(1) of the Act.

28 Feb 2025|11:13 PM
Read More
Top Stocks for Today - 24th January 2025

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

24 Jan 2025|07:50 AM
Read More
Mankind Pharma Q3 Profit Falls 16%, Revenue Jumps 24%

The company reported a good growth in EBITDA of 36.8% to ₹830 crore in the quarter against ₹606.5 crore in Q3 FY24.

23 Jan 2025|11:57 PM
Read More
Mankind Pharma Secures ₹5,000 Crore NCDs by Pledging 56.31% Stake in BSV

The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series.

8 Jan 2025|04:01 PM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.